FDA Warns Yaz, Yasmin, Ocella & Beyaz Users About Blood Clot Risks

By Sarah Mirando | August 6, 2012

Category: Pharmaceuticals

By Sarah Pierce

The U.S. Food and Drug Administration issued a press release April 10, 2012 stating it found evidence that drospirenone-containing contraceptives like Yaz, Yasmin, Ocella and Beyaz may be associated with a higher risk of blood clots than other forms of birth control. The announcement comes as no surprise to thousands of women who have suffered blood clot injuries such as pulmonary embolism, deep vein thrombosis, heart attack and stroke after taking Yaz, Yasmin, Ocella, Beyaz and other drospirenone-containing birth control pills. Nearly 10,000 lawsuits have been filed in the United States claiming serious side effects from these types of birth control medications.

Drospirenone is a newly-developed “fourth generation” synthetic version of the female hormone progesterone, commonly known as progestin. After reviewing studies evaluating the risk of blood clots associated with taking birth control pills containing drospirenone, the FDA determined nearly a three-fold increased risk of blood clots compared to older birth control pills containing levonorgestrel or other form of progestin. As a result, the FDA is updating the warning labels on the following birth control pills to include information about the risk of blood clots:

Yasmin

Yaz

Ocella

Beyaz

Gianvi

Loryna

Syeda

Zarah

Safyral

The FDA is also recommending that women consult their doctors about their risk for blood clots prior to taking a drospirenone birth control.

The warning follows thousands of lawsuits filed by women who suffered blood clot injuries caused by these types of birth control. To date, more than 10,000 Yasmin, Yaz, Ocella and Beyaz lawsuits have been filed across the country by women who have suffered serious side effects from these pills. In addition to suffering blood clots, these lawsuits cite a litany of side effects and injuries, including:

Heart attack

Stroke

Pulmonary embolism

Deep vein thrombosis

Sudden death

All lawsuits concerning Yaz, Yasmin, Ocella and Beyaz have been consolidated into a multi-district litigation (MDL) before Judge David L. Herndon in the U.S. District Court for the Southern District of Illinois. Any Yasmin lawsuit, Yaz lawsuit, Ocella lawsuit or Beyaz lawsuit filed from now on will be transferred to this MDL for pre-trial proceedings. While lawsuits in the Yasmin/Yaz MDL are handled in a similar manner to that of a class action lawsuit, there are some key differences. For one, each lawsuit retains its status as an individual case, with each Plaintiff retaining her own attorney. As such, each Plaintiff will receive her own individual lawsuit settlement based on the severity of her injuries, instead of sharing a class action lawsuit settlement. If the MDL does not resolve during the pretrial proceedings, the individual lawsuits will be returned to the courts where they were originally filed to try and reach a resolution on their own.

If you took Yaz, Yasmin, Ocella, Beyaz or another drospirenone-containing birth control product and suffered a blood clot injury, you may have legal options to recover the medical expenses you incurred and the pain and suffering you endured from the drug’s manufacturer. A blood clot compensation specialist can provide a free consultation about your legal options.

Visit the Yaz/Yasmin, Beyaz & Ocella Birth Control Pill Class Action Lawsuit Settlement & Investigation page for more information. Yaz/Yasmin, Beyaz and Ocella attorneys are actively investigating all claims of blood clot injuries, including pulmonary embolism, deep vein thrombosis, heart attack and stroke. Filing a Yasmin/Yaz lawsuit, Ocella lawsuit or Beyaz lawsuit is the first step to getting the compensation you deserve. The attorneys handling this investigation don’t get paid unless you win or settle.

Updated August 6th, 2012

{loadposition content_postads}

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.

LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement

Various Trademarks held by their respective owners.